AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 171 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $206,000 | +5.1% | 21,888 | -14.6% | 0.00% | – |
| Q2 2020 | $196,000 | -96.7% | 25,625 | -94.8% | 0.00% | -100.0% |
| Q4 2019 | $5,984,000 | -35.4% | 491,713 | -38.7% | 0.01% | -53.3% |
| Q3 2019 | $9,270,000 | +856.7% | 802,607 | +727.4% | 0.02% | +1400.0% |
| Q2 2019 | $969,000 | -82.5% | 97,007 | -77.4% | 0.00% | -87.5% |
| Q1 2019 | $5,524,000 | -7.2% | 428,865 | +9.4% | 0.01% | -11.1% |
| Q4 2018 | $5,955,000 | -44.4% | 392,030 | -26.9% | 0.01% | -30.8% |
| Q3 2018 | $10,720,000 | +24.7% | 536,010 | +21.6% | 0.01% | +18.2% |
| Q2 2018 | $8,597,000 | -10.1% | 440,879 | -7.1% | 0.01% | -15.4% |
| Q1 2018 | $9,567,000 | +12.4% | 474,796 | -26.1% | 0.01% | +8.3% |
| Q4 2017 | $8,508,000 | -69.9% | 642,098 | -58.2% | 0.01% | -72.1% |
| Q3 2017 | $28,308,000 | +5.9% | 1,534,292 | +5.6% | 0.04% | -10.4% |
| Q2 2017 | $26,724,000 | +295.3% | 1,452,373 | +384.4% | 0.05% | +300.0% |
| Q1 2017 | $6,761,000 | +4.5% | 299,822 | +61.2% | 0.01% | -14.3% |
| Q4 2016 | $6,472,000 | +20.0% | 185,963 | -15.5% | 0.01% | +55.6% |
| Q3 2016 | $5,394,000 | +87.9% | 220,078 | +83.4% | 0.01% | +28.6% |
| Q2 2016 | $2,870,000 | +15.7% | 120,000 | +13.2% | 0.01% | +16.7% |
| Q1 2016 | $2,480,000 | -93.9% | 105,964 | -92.1% | 0.01% | -92.9% |
| Q4 2015 | $40,462,000 | +55.3% | 1,340,237 | +104.4% | 0.08% | +70.0% |
| Q3 2015 | $26,050,000 | -65.6% | 655,675 | -40.2% | 0.05% | -65.0% |
| Q2 2015 | $75,734,000 | +52.4% | 1,096,638 | +20.6% | 0.14% | +55.4% |
| Q1 2015 | $49,697,000 | +54.8% | 909,205 | +20.7% | 0.09% | +35.3% |
| Q4 2014 | $32,109,000 | +12.9% | 753,386 | -15.5% | 0.07% | -5.6% |
| Q3 2014 | $28,443,000 | +109.7% | 891,337 | +36.2% | 0.07% | +89.5% |
| Q2 2014 | $13,561,000 | -8.8% | 654,500 | -14.8% | 0.04% | -11.6% |
| Q1 2014 | $14,865,000 | +311.1% | 768,214 | +415.8% | 0.04% | +290.9% |
| Q4 2013 | $3,616,000 | +854.1% | 148,927 | +743.8% | 0.01% | +1000.0% |
| Q3 2013 | $379,000 | -27.7% | 17,650 | -25.1% | 0.00% | -50.0% |
| Q2 2013 | $524,000 | – | 23,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |